XML 57 R29.htm IDEA: XBRL DOCUMENT
v3.25.2

Stockholders’ Deficit (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Equity [Abstract] |
Schedule of Dividends Payable | The following is a summary of the Company’s dividends: Schedule of Dividends Payable
|  | Series A Convertible Preferred Stock |  | Series B Convertible Preferred Stock |  | Total Dividends Payable
Shares issued and outstanding |  |  | 363,000 |  |  |  | 140,000 |  |  |  |  |
Stated value per share |  | $ | 10 |  |  | $ | 10 |  |  |  |  |
Dividend rate (10%/12%) |  |  | 10 | % |  |  | 12 | % |  |  |  |
Dividend shares due per year |  |  | 363,000 |  |  |  | 168,000 |  |  |  |  |
Market price - at issuance date |  |  | 2.76 |  |  |  | 2.76 |  |  |  |  |
Minimum price - 70%/80% discount to market price |  |  | 80 | % |  |  | 70 | % |  |  |  |
Conversion price |  |  | 2.21 |  |  |  | 1.93 |  |  |  |  |
Dividend shares due per quarter |  |  | 41,101 |  |  |  | 21,739 |  |  |  | 62,840 |
Equivalent common shares - per year |  |  | 164,402 |  |  |  | 86,957 |  |  |  | 251,359 |
Schedule of Series A and B Convertible Preferred Stock Dividends Payable | The following represents the Company’s Series A and B convertible preferred stock quantity of shares due at June 30, 2025 and December 31, 2024: Schedule of Series A and B Convertible Preferred Stock Dividends Payable
|  | Series A Convertible Preferred Stock |  | Series B Convertible Preferred Stock |  | Total Dividends Payable
December 31, 2024 |  |  | 61,204 |  |  |  | 32,372 |  |  |  | 93,576 |
Dividends payable, shares |  |  | 61,204 |  |  |  | 32,372 |  |  |  | 93,576 |
Accrued dividends payable - Series A and Series B convertible preferred stock |  |  | 82,200 |  |  |  | 43,478 |  |  |  | 62,840 |
Accrued dividends payable |  |  | 82,200 |  |  |  | 43,478 |  |  |  | 62,840 |
Payment of accrued dividends as common stock |  |  | (102,304 | ) |  |  | (54,111 | ) |  |  | (156,414 | )
Payment of accrued dividends as common stock, shares |  |  | (102,304 | ) |  |  | (54,111 | ) |  |  | (156,414 | )
June 30, 2025 |  |  | 41,100 |  |  |  | 21,739 |  |  |  | 62,839 |
Dividends payable, shares |  |  | 41,100 |  |  |  | 21,739 |  |  |  | 62,839 |
The following represents the Company’s Series A and B convertible preferred stock valuation due at June 30, 2025 and December 31, 2024:
|  | Series A Convertible Preferred Stock |  |  | Series B Convertible Preferred Stock |  |  | Total Dividends Payable |
December 31, 2024 |  | $ | 168,923 |  |  | $ | 89,348 |  |  | $ | 258,271 |
Dividends payable |  | $ | 168,923 |  |  | $ | 89,348 |  |  | $ | 258,271 |
Accrued dividends payable - Series A and Series B convertible preferred stock |  |  | 226,876 |  |  |  | 120,000 |  |  |  | 346,876 |
Payment of accrued dividends as common stock |  |  | (340,314 | ) |  |  | (149,348 | ) |  |  | (489,662 | )
June 30, 2025 |  | $ | 113,438 |  |  | $ | 60,000 |  |  | $ | 173,438 |
Dividends payable |  | $ | 113,438 |  |  | $ | 60,000 |  |  | $ | 173,438 |
Schedule of Company Nonvested Shares | A summary of the Company’s non-vested shares (due to service time-based restrictions) as of June 30, 2025 and December 31, 2024, is presented below: Schedule of Company Nonvested Shares
|  |  |  |  | Weighted Average |
|  | Number of |  |  | Grant Date |
Non-Vested Shares |  | Shares |  |  | Fair Value |
Balance - December 31, 2023 |  |  | 114,336 |  |  |  | 6.40 |
Granted |  |  | - |  |  |  | - |
Vested |  |  | (88,336 | ) |  |  | 5.15 |
Cancelled/Forfeited |  |  | - |  |  |  | - |
Balance - December 31, 2024 |  |  | 26,000 |  |  | $ | 6.40 |
Granted |  |  | 1,000,000 |  |  |  | 3.18 |
Vested |  |  | 13,000 |  |  |  | 6.40 |
Cancelled/Forfeited |  |  | - |  |  |  | - |
Balance - June 30, 2025 |  |  | 1,039,000 |  |  | $ | 3.22 |
Schedule of Stock Warrant Activity | Warrant activity for the three months ended June 30, 2025 and December 31, 2024 are summarized as follows: Schedule of Stock Warrant Activity
|  |  |  |  |  |  |  | Weighted |  |  |  |
|  |  |  |  | Weighted |  |  | Average |  |  |  |
|  |  |  |  | Average |  |  | Remaining |  |  | Aggregate |
|  | Number of |  |  | Exercise |  |  | Contractual |  |  | Intrinsic |
Warrants |  | Warrants |  |  | Price |  |  | Term (Years) |  |  | Value |
Outstanding - December 31, 2023 |  |  | 81,452 |  |  | $ | 10.36 |  |  |  | 1.22 |  |  | $ | 36,030 |
Vested and Exercisable - December 31, 2023 |  |  | 81,452 |  |  | $ | 10.36 |  |  |  | 1.22 |  |  | $ | 36,030 |
Unvested and non-exercisable - December 31, 2023 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Cancelled/Forfeited |  |  | (35,107 | ) |  | $ | 17.28 |  |  |  | - |  |  |  | - |
Outstanding - December 31, 2024 |  |  | 46,345 |  |  | $ | 5.12 |  |  |  | 0.65 |  |  | $ | 9,156 |
Vested and Exercisable - December 31, 2024 |  |  | 46,345 |  |  | $ | 5.12 |  |  |  | 0.65 |  |  | $ | 9,156 |
Unvested and non-exercisable - December 31, 2024 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Granted |  |  | 250,000 |  |  | $ | 3.75 |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Cancelled/Forfeited |  |  | (19,062 | ) |  | $ | 4.37 |  |  |  | - |  |  |  | - |
Outstanding - June 30, 2025 |  |  | 277,282 |  |  | $ | 3.94 |  |  |  | 4.33 |  |  | $ | - |
Vested and Exercisable - June 30, 2025 |  |  | 277,282 |  |  | $ | 3.94 |  |  |  | 4.33 |  |  | $ | - |
Unvested and non-exercisable - June 30, 2025 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |

X
- Definition Schedule of Series A and B Convertible Preferred Stock Dividends Payable [Text Block] + References No definition available. + Details
Name: | NXXT_ScheduleOfSeriesAAndBConvertiblePreferredStockDividendsPayableTextBlock
Namespace Prefix: | NXXT_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Subparagraph (c) -Paragraph 2 -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all or some of the information related to dividends declared, but not paid, as of the financial reporting date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3 + Details
Name: | us-gaap_ScheduleOfDividendsPayableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration